Addressing kyphoscoliosis in Gaucher’s disease: a multidisciplinary approach to a rare case Authors: Jianwei Guo, Li Zhang, Changlin Lv, Tianyu Bai, Jiale Shao, Yongming Xi Published: 2026 ABSTRACT AbstractBackgroundGaucher’s disease (GD) is a rare autosomal recessive disorder caused by mutations in the GBA gene, leading to glucocerebrosidase deficiency and the accumulation of glucosyl ceramide in the bone marrow, which can result in skeletal complications such as scoliosis and kyphosis. Surgical interventions for orthopedic manifestations in GD are challenging and have been rarely reported.Study designA clinical retrospective study.Case presentationWe report an 18-year-old female with Gaucher’s disease who presented with kyphoscoliosis and was treated with a combination of medical and surgical interventions. Preoperatively, she underwent enzyme replacement therapy and cephalic loop traction to correct anemia, coagulation abnormalities, and improve spinal deformity flexibility. She then underwent T12 column resectomy and Smith-Peterson resectomies at T5-10 and L1-3, followed by kyphoscoliosis correction, internal fixation, and fusion surgery. Postoperatively, there was a significant correction of the main coronal curve and kyphosis, with stable outcomes at the 3.5-year follow-up.ConclusionThis case represents a rare instance of kyphoscoliosis due to Gaucher’s disease treated with vertebral resection and fusion surgery. The perioperative management, including enzyme replacement therapy and spinal traction, was crucial for the surgical success. This report contributes to the understanding of surgical treatment options for severe spinal deformities in GD and highlights the importance of a multidisciplinary approach. Further studies with longer follow-up periods and additional cases are needed to validate the long-term effectiveness of this technique.Supplementary InformationThe online version contains supplementary material available at 10.1186/s12891-026-09827-5.Keywords: Gaucher's disease, Kyphoscoliosis, Vertebral resection, Fusion surgery, Enzyme replacement therapy Introduction Gaucher’s disease (GD) is a rare autosomal recessive genetic disorder with the prevalence of approximately 1/57,000 births [1]. It was firstly described by Philippe Gaucher in 1882 in a 34-year-old patient with splenomegaly but without neoplasm. It is caused by pathogenic mutations of the GBA gene encoding the enzyme glucocerebrosidase (acid β-glucosidase), which decrease the activity of glucocerebrosidase and accumulate its substrate (glucocerebroside) in the reticuloendothelial system (the liver, spleen, bone marrow, etc.) and transform the macrophages into Gaucher cells [2–5]. The infiltration of bone marrow, spleen, and liver by Gaucher cells results in the clinical manifestations of the disease, such as cytopenia, splenomegaly, hepatomegaly, and bone lesions. The accumulation of glucosyl ceramide in the bone marrow results in pathologic fractures, expanded medullary cavities, osteonecrosis and scoliosis [6–8]. There have been reports of surgical treatment of orthopaedics diseases due to Gaucher’s disease [9–12]. However, most of cases were associated with pathological vertebral compression fractures associated with Gaucher’s disease and the images were blurred or incomplete [9–12]. Here, we presented a case with kyphoscoliosis caused by Gaucher’s disease and complete clinical manifestation and radiological images were presented. Case report An 18-year-old female patient, diagnosed with Gaucher’s disease, was referred to our clinic due to lumbar back pain. The patient was diagnosed with Gaucher’s disease type 1 (chronic non-neuronopathic type) 5 years prior to admission, confirmed by clinical manifestations, enzyme activity detection, and genetic testing at the referring hospital. She received the diagnosis of Gaucher’s disease approximately 5 years ago and underwent biweekly imiglucerase replacement therapy. At the age of 10, she developed an uneven back and received treatment with a brace. Unfortunately, conservative treatment proved ineffective. Upon her visit to our clinic, she reported experiencing mild lumbar back pain and experiencing difficulty in breathing during physical activities. A comprehensive clinical and radiological examination was conducted, revealing an uneven back and evident kyphoscoliosis (Fig. 1a and b). No café-au-lait spots, hair abnormalities, paresthesias, or numbness were observed on the skin, and there were no limitations in range of motion. Thanks to regularly biweekly imiglucerase (60 U/kg per dose) regularly to optimize hematologic and coagulation parameters, the hematological examination results upon admission were basically normal: Hemoglobin (Hb) 126 g/L, Platelet Count 206 × 10⁹/L, Prothrombin Time (PT) 17.30s, Activated Partial Thromboplastin Time (APTT) 29.40s, Fibrinogen (FIB) 2.49 g/L, Fibrinogen (FIB) 2.49 g/L. Patient’s preoperative and postoperative back appearance. Figure 1a and b illustrate the preoperative backside and lateral views of the patient, respectively, revealing apparent unevenness and asymmetry in the back region. The patient exhibited a noticeable convexity in the lateral and posterior regions. Following the corrective surgery, Fig. 1c and d showcase the postoperative backside and lateral views, respectively. A significant improvement in back symmetry and projection is evident when comparing the postoperative images to the preoperative ones. The patient’s back appearance demonstrates a more balanced and harmonious contour, with a satisfactory correction of the lateral and posterior convexity X-ray imaging of the entire spine showed the degree of main coronal curve was 67.7° and the degree of kyphosis was 107.5°(Fig. 2a and b). Significant coronal imbalance, by a C7-CSVL (Central Sacral Vertical Line) offset of 26.6 mm and pronounced sagittal imbalance, by an SVA (Sagittal Vertical Axis) measurement of 96.3 mm, were seen before surgery.CT examination did not reveal any vertebral fractures or malformations (Fig. 2c), and MRI examination did not detect any spinal cord malformations (Fig. 2d). However, multiple wedge-shaped vertebra were found during CT and MRI examination (Fig. 2c and d). Pulmonary examination indicated moderate ventilatory dysfunction. Regular imiglucerase replacement therapy was used to correct anemia and coagulation abnormalities and cephalic loop traction was performed to improve the flexibility of spinal deformity and ventilatory dysfunction. Traction was performed all days except eating, bathing and exercise time. The traction weight was gradually increased based on the patient’s age, body weight (48 kg), and spinal flexibility assessment, initial weight of 3 kg (6.25% of body weight) for the first 3 days to allow the patient to adapt; Increased to 4 kg (8.33% of body weight) for the next weeks as tolerated; Maintained at 5 kg (10.42% of body weight) for about 2 weeks for stable traction correction.The weight adjustment was guided by daily clinical evaluations (including back pain score, skin condition, and neurological status) to ensure safety without adverse events (e.g., numbness, dizziness, or skin breakdown). Preoperative and Postoperative Radiological Images. Figure 2a and b present X-ray images of the entire spine, demonstrating the degree of main coronal curve was 67.7° and the degree of sagittal kyphosis was 107.5°, respectively. Figure 2c, obtained through CT examination, reveals no vertebral fractures or malformations but shows the presence of multiple wedge-shaped vertebrae. Similarly, Fig. 2d, obtained through MRI examination, does not detect any spinal cord malformations but confirms the presence of wedge-shaped vertebrae. The patient underwent a surgical procedure consisting of T12 column resectomy, T5-10 and L1-3 Smith-Peterson resectomies, as well as T5-L3 kyphoscoliosis correction, internal fixation, and fusion surgery. The surgical outcome, as depicted in Fig. 2e and f, demonstrates a satisfactory correction of the main curve to 13.8° and the kyphosis to 54.9°. At the 3.5-year follow-up, Fig. 2g and h demonstrate no loss of correction The patient underwent T12 column resectomy, T5-10 and L1-3 Smith-Peterson resectomies, as well as T5-L3 kyphoscoliosis correction, internal fixation, and fusion surgery. Intraoperative somatosensory evoked potentials (SSEPs) and motor evoked potentials (MEPs) were continuously used to monitor spinal cord function, with no significant changes detected during osteotomy or correction. The intraoperative bleeding was approximately 850 ml, with 600 ml of autologous blood transfusion and 2u of allogeneic red blood cell transfusion, as well as 400 ml of plasma transfusion. The surgical outcome was satisfactory (Fig. 1c and d), with the main curve corrected to 13.8°and the kyphosis corrected to 54.9°(Fig. 2e and f). Postoperatively, the coronal balance was corrected to a much more favorable offset of 5 mm, and the sagittal balance was corrected to 41 mm, which represents a significant improvement in the sagittal plane alignment. At the 3.5-year follow-up, no loss of correction was observed (Fig. 2g and h). The correction outcomes of the radiographic parameter and the quality of life scores following the spinal deformity surgery are summarized in Table 1. Table 1The patient’s radiographic evaluation and quality of life scores based on SF-36ParameterPre-operativePost-operativeLast follow-upradiographic evaluationmain thoracic cobb angel67.7°13.8°18.2°total kyphosis angle107.5°54.9°58.9°coranal balance (C7-CSVL, mm)26.625.92.85saggital balance (SVA, mm)96.354.949.7Lumbar lordosis61.9°49.8°53.7°PT25.0°11.7°13.7°PI46.5°43.4°45.3°SS21.5°31.7°31.6°quality of life score (SF-36)Physical functioning506085Physical role functioning405075Bodily pain305065General health506085Vitality405080Social functioning506075Emotional role functioning507080Mental health607080 The patient’s radiographic evaluation and quality of life scores based on SF-36 Discussion Gaucher’s disease is a rare hereditary metabolic disorder caused by autosomal recessive mutations in the GBA1 gene [2, 5]. These mutations result in a deficiency of the enzyme glucocerebrosidase, which leads to the accumulation of glucocerebroside in the reticuloendothelial system [13]. This condition can cause various diseases due to the infiltration of Gaucher cells in the bone marrow, spleen, and liver [14]. There are three clinical subtypes of Gaucher’s disease based on the presence and severity of neurological symptoms. Type 1, also known as chronic non-neuronopathic or adult Gaucher’s disease, is characterized by the absence of significant neurological impairment (OMIM #230800, GD1). Type 2, known as acute neuronopathic Gaucher’s disease, presents with early clinical manifestations and significant neurological impairment, often leading to early death (OMIM #230900, GD2). Type 3, known as chronic neuronopathic Gaucher’s disease, exhibits similar manifestations to type 2 but with less severity (OMIM #231000, GD3) [15]. The case described in this article belongs to type 1 Gaucher’s disease, which is the most common clinical form of the disease in the Western world. It is typically characterized by visceral manifestations such as splenomegaly and hepatomegaly, hematologic abnormalities including thrombocytopenia and anemia, and various skeletal manifestations such as painful bone crises, avascular necrosis, osteopenia, osteoporosis, and focal lytic lesions. Orthopedic issues are a common feature in patients with Gaucher’s disease, often presenting as pathologic fractures in weight-bearing bones and avascular necrosis of the femoral head [16, 17]. While spinal involvement in Gaucher’s disease has been reported, most cases involve vertebral compression fractures and kyphosis resulting from these fractures [8, 10, 11, 16, 17]. In cases where there is mild vertebral wedging and no neurological complications, conservative treatment is usually opted for. However, for patients with progressing localized kyphosis or symptomatic neurological damage, surgical stabilization and decompression are necessary to prevent further deformity and avoid complications. There have been very few reports of Gaucher’s disease patients with kyphoscoliosis caused by vertebral body wedging. To the best of our knowledge, this is the first reported case of GD-related kyphoscoliosis (combined coronal and sagittal deformity) treated with a combination of pVCR and multi-level SPO, complementing prior reports of isolated kyphosis correction in GD patients [10]. In addition to surgical techniques, there are several methods to address intraoperative complications associated with Gaucher’s disease and kyphoscoliosis. These methods aim to mitigate the effects of glucocerebroside accumulation and reduce the risk of intraoperative hemorrhage. They include: Enzyme Replacement Therapy (ERT): Prior to surgery, GD patients should undergo ERT, which involves intravenous infusion of synthetic glucocerebrosidase. ERT helps break down accumulated glucocerebroside, leading to reduced organ enlargement (such as the spleen and liver) and improved hematological parameters, including platelet and hemoglobin levels. This can alleviate easy bruising and decrease bleeding during surgery. ERT also contributes to improving bone density, reducing bone pain, and preventing skeletal complications associated with Gaucher’s disease [18]. Enzyme Replacement Therapy (ERT): Prior to surgery, GD patients should undergo ERT, which involves intravenous infusion of synthetic glucocerebrosidase. ERT helps break down accumulated glucocerebroside, leading to reduced organ enlargement (such as the spleen and liver) and improved hematological parameters, including platelet and hemoglobin levels. This can alleviate easy bruising and decrease bleeding during surgery. ERT also contributes to improving bone density, reducing bone pain, and preventing skeletal complications associated with Gaucher’s disease [18]. Preoperative Spinal Traction: For severe spinal kyphoscoliosis, preoperative spinal traction can be beneficial. It gradually reduces spinal curvature and increases the flexibility of the scoliosis [19, 20]. This makes it easier to perform surgical correction of the scoliosis, reduces the complexity of the correction procedure, and decreases intraoperative bleeding. Preoperative Spinal Traction: For severe spinal kyphoscoliosis, preoperative spinal traction can be beneficial. It gradually reduces spinal curvature and increases the flexibility of the scoliosis [19, 20]. This makes it easier to perform surgical correction of the scoliosis, reduces the complexity of the correction procedure, and decreases intraoperative bleeding. Antifibrinolytic Drugs: Intraoperatively, antifibrinolytic drugs like tranexamic acid can be administered to reduce blood loss [21, 22]. These drugs help to control bleeding by inhibiting the breakdown of blood clots, thereby decreasing the amount of intraoperative hemorrhage. Antifibrinolytic Drugs: Intraoperatively, antifibrinolytic drugs like tranexamic acid can be administered to reduce blood loss [21, 22]. These drugs help to control bleeding by inhibiting the breakdown of blood clots, thereby decreasing the amount of intraoperative hemorrhage. Postoperative Orthosis: GD patients often exhibit compromised bone quality [23]. It is recommended that they wear orthoses for a minimum duration of three months post-surgery. Crucially, evaluating bone fusion at the surgical site is imperative prior to the removal of the orthosis. This step is vital to ensure proper healing and to avoid complications related to fragile bones commonly seen in GD. Postoperative Orthosis: GD patients often exhibit compromised bone quality [23]. It is recommended that they wear orthoses for a minimum duration of three months post-surgery. Crucially, evaluating bone fusion at the surgical site is imperative prior to the removal of the orthosis. This step is vital to ensure proper healing and to avoid complications related to fragile bones commonly seen in GD. Postoperative Hemoglobin (Hb) and Albumin Check: Patients with GD typically exhibit dysfunction in the reticuloendothelial system, leading to lower levels of hemoglobin (Hb) and albumin [5, 14]. Monitoring of Hb and albumin levels in GD patients is critical. Especially in the postoperative phase, lower levels of these biomarkers may increase the risk of infections and impede wound healing. Regular monitoring and appropriate interventions to manage these levels can significantly improve postoperative recovery and reduce the risk of complications. Postoperative Hemoglobin (Hb) and Albumin Check: Patients with GD typically exhibit dysfunction in the reticuloendothelial system, leading to lower levels of hemoglobin (Hb) and albumin [5, 14]. Monitoring of Hb and albumin levels in GD patients is critical. Especially in the postoperative phase, lower levels of these biomarkers may increase the risk of infections and impede wound healing. Regular monitoring and appropriate interventions to manage these levels can significantly improve postoperative recovery and reduce the risk of complications. Postoperative Consultation with Pediatric Clinicians: Gaucher’s disease, a rare autosomal recessive genetic disorder, often requires multidisciplinary management [24]. For patients unaware of the etiology of their condition, a postoperative consultation with pediatric clinicians specializing in genetic disorders is essential. Such consultations provide patients and their families with vital information on the nature of GD, its management, and implications for future generations. Genetic counseling as part of this consultation can be instrumental in understanding the disease’s hereditary aspects and planning for family health. Postoperative Consultation with Pediatric Clinicians: Gaucher’s disease, a rare autosomal recessive genetic disorder, often requires multidisciplinary management [24]. For patients unaware of the etiology of their condition, a postoperative consultation with pediatric clinicians specializing in genetic disorders is essential. Such consultations provide patients and their families with vital information on the nature of GD, its management, and implications for future generations. Genetic counseling as part of this consultation can be instrumental in understanding the disease’s hereditary aspects and planning for family health. This study has its limitations. Firstly, the case was diagnosed in other hospital. Genetic diagnosis was not performed again in our hospital. Secondly, all the intraoperative bone were used to perform fusion procedure, and no bone was used to perform pathological diagnosis and detect Gaucher cell. Thirdly, the follow-up time was limited. Longer follow-up and additional cases will be needed in the future. Conclusion In this article, we present a rare case of kyphoscoliosis associated with Gaucher’s disease. To the best of our knowledge, this is the first reported instance of kyphoscoliosis attributed to Gaucher’s disease that was effectively addressed through a surgical procedure involving vertebral resection and fusion. However, it is important to acknowledge the limitations of our knowledge and the need for further research. Additional cases and extended follow-up periods will be necessary in the future to thoroughly assess the surgical outcomes and efficacy of this approach. Supplementary Information Supplementary Material 1. Acknowledgements We gratefully acknowledge the contributions of our clinical team and the patients who participated in this study. Special thanks to Yongming Xi for his invaluable support. Authors' contributions JG and LZ: designed the study and drafted the article; CL, TB and JS: collected and analyzed the data and radiographs; YX: performed the surgery and supervised study design and manuscript writing. All authors have read and approved the final submitted manuscript. Funding This work was supported by Taishan Scholars Program, Shandong province, China (NO.ts20190985), National Natural Science Foundation of China (NO. 81871804), 2022 Qingdao Medical and Health Research Guidance Project (2022-WJZD187) and the National High Level Hospital Clinical Research Funding (2022-PUMCH-D-004). Data availability The data included in this study are available upon reasonable request by contacting the first author or the corresponding author. Declarations Ethics approval and consent to participate The patient has signed a written consent form allowing the use of her de-identified imaging and photographic data for publication purposes. All personal identifiers have been removed to ensure the anonymity and confidentiality of the patient. Consent for publication This article is approved by the IRB of Affiliated Hospital of Qingdao University. The patient has signed consent forms to publish the images for this study. Competing interests The authors declare no competing interests. Footnotes Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations. Jianwei Guo and Li Zhang contributed equally to this work. References Associated Data Supplementary Materials Supplementary Material 1. Data Availability Statement The data included in this study are available upon reasonable request by contacting the first author or the corresponding author.